What does CUSIP 868459108 represent in this 13F holders report?

CUSIP 868459108 is the security identifier for SUPN - SUPERNUS PHARMACEUTICALS, INC. - Common Stock used to aggregate holder disclosures.

How many institutions held SUPN - SUPERNUS PHARMACEUTICALS, INC. - Common Stock in Q1 2022?

220 institutional investors reported SUPN - SUPERNUS PHARMACEUTICALS, INC. - Common Stock for Q1 2022. Use the holders table for investor-level position and value details.

SUPERNUS PHARMACEUTICALS, INC. - Common Stock (SUPN)

CUSIP: 868459108

Q1 2022 13F Holders as of 31 Mar 2022

Security type / class: Equity / Common Stock
Total 13F shares: 53,502,805
Total 13F value: $1,728,247,579
Share change: -1,388,619
Put/Call ratio: 96%
SEC-reported price per share: $32.32
Number of holders: 220
Value change: -$41,233,819
Number of buys: 95
Number of sells: 130
Shares outstanding: 57,671,650

Security key

868459108

Report period

Q1 2022

Institutions

220

Top holders

SUPN full security history Ownership snapshot Full 13F holder table SUPERNUS PHARMACEUTICALS, INC. SEC filings SUPERNUS PHARMACEUTICALS, INC. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of SUPN - SUPERNUS PHARMACEUTICALS, INC. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

BlackRock Finance, Inc.

Disclosed value leader

BlackRock Finance, Inc.

Comparable rows

15/15

Latest evidence

31 Dec 2021

13F Lead comparable stake: 15% Showing 1-6 of 15 holder rows.

Quick read

BlackRock Finance, Inc. leads the comparable SEC ownership view at 15%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens BlackRock Finance, Inc.'s linked filing trail.

Comparable ownership Top 5

BlackRock Finance, Inc. 15%

VANGUARD GROUP INC 9.6%

ARMISTICE CAPITAL, LLC 7.2%

DIMENSIONAL FUND ADVISORS LP 3.9%

MACQUARIE GROUP LTD 3.8%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
BlackRock Finance, Inc.	13F Company 13F	15%	$246,431,000 8,451,022 shares	—	31 Dec 2021
VANGUARD GROUP INC	13F Company 13F	9.6%	$160,764,000 5,513,149 shares	—	31 Dec 2021
ARMISTICE CAPITAL, LLC	13F Company 13F	7.2%	$120,606,000 4,136,000 shares	—	31 Dec 2021
DIMENSIONAL FUND ADVISORS LP	13F Company 13F	3.9%	$65,339,000 2,240,621 shares	—	31 Dec 2021
MACQUARIE GROUP LTD	13F Company 13F	3.8%	$63,319,000 2,171,428 shares	—	31 Dec 2021
GW&K Investment Management, LLC	13F Company 13F	3.2%	$53,551,000 1,836,466 shares	—	31 Dec 2021

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

220

53,502,805

Rows available

220

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2022 vs Q1 2022 Across Filers

Q1 2022 holders

220

Q1 2022 holders

220

Holder diff

Investor	Q1 2022 Shares	Q1 2022 Shares	Share Diff	Share Chg %	Q1 2022 value	Q1 2022 value	Value change	Value Chg %